Qube Research & Technologies (QRT)’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$784K Sell
6,500
-7,500
-54% -$820K ﹤0.01% 2505
2026
Q1
$1.16M Sell
14,000
-24,900
-64% -$2.13M ﹤0.01% 2424
2025
Q4
$3.33M Buy
38,900
+3,300
+9% +$276K ﹤0.01% 1997
2025
Q3
$2.97M Sell
35,600
-100
-0.3% -$9.13K ﹤0.01% 2029
2025
Q2
$3.62M Buy
35,700
+20,200
+130% +$2.06M ﹤0.01% 1900
2025
Q1
$1.65M Buy
15,500
+13,200
+574% +$1.37M ﹤0.01% 2043
2024
Q4
$252K Buy
2,300
+1,700
+283% +$198K ﹤0.01% 2773
2024
Q3
$86.9K Buy
+600
New +$81.9K ﹤0.01% 2767
2024
Q1
Sell
-1,000
Closed -$93.4K 4524
2023
Q4
$93.4K Sell
1,000
-130,200
-99% -$12M ﹤0.01% 3120
2023
Q3
$11.6M Buy
+131,200
New +$13.5M 0.03% 593

Other funds holding CROX

Qube Research & Technologies (QRT)'s CROX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Crocs (CROX) in Q2 2026: 23,889 shares worth $2.88M. The stake represents ﹤0.01% of the portfolio and ranks #1937 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CROX as recently as Q3 2024.

Qube Research & Technologies (QRT) first reported a position in CROX in Q4 2019 and has held it in 18 quarters since. The position peaked at $98.6M in Q4 2023. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 23,889 shares of Crocs worth $2.88M as of Q2 2026.
  • Crocs was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Crocs made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1937 holding.
  • Qube Research & Technologies (QRT) first reported a position in Crocs in Q4 2019 and has held it in 18 quarters since.
  • Qube Research & Technologies (QRT)'s Crocs position peaked at $98.6M in Q4 2023.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.